Home
About
Overview
Sharing Data
ORCID
Help
History (50)
Hemlock
Pembrolizumab plus Chemotherapy in Lung Cancer.
Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides.
Early parenchymal contrast extravasation predicts subsequent hemorrhage progression, clinical deterioration, and need for surgery in patients with traumatic cerebral contusion.
MET pathway as a therapeutic target.
See All 50 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
MET pathway as a therapeutic target.
MET pathway as a therapeutic target. J Thorac Oncol. 2009 Apr; 4(4):444-7.
View in:
PubMed
subject areas
Animals
Humans
Neoplasms
Phosphorylation
Proto-Oncogene Proteins
Proto-Oncogene Proteins c-met
Receptors, Growth Factor
Signal Transduction
authors with profiles
Ravi Salgia